Clinical Trial Update: Levosimendan Versus Placebo Before Tricuspid Valve Surgery in Patients With Right Ventricular Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing levosimendan to placebo in patients with right ventricular dysfunction undergoing tricuspid valve surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Right Ventricular Dysfunction
• Tricuspid Valve Disease

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Patients Referred for an Isolated or a Combined Surgical Correction of Functional Moderate to Severe Tricuspid | Phase 3 | Status: UNKNOWN